PKBK:NASDAQParke Bancorp, Inc. Analysis
Data as of 2026-06-17 - not real-time
$31.73
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Parke Bancorp is trading at $31.73, comfortably above its 20‑day SMA ($31.34) and 50‑day SMA ($30.61), with the price sitting between a clear support level at $30.07 and resistance near $32.44. Technical indicators are bullish – the MACD histogram is positive and the RSI sits at 59, indicating room for upside without being overbought.
Fundamentally, the stock appears markedly undervalued: a trailing P/E of 9.1 is well below the industry average of 17.2, and the DCF‑derived fair value of $93.7 suggests a >200% upside. Strong operating margins (70% operating, 50% profit), a modest 35% revenue growth year‑over‑year, and a low payout ratio of 20% support a sustainable 2.26% dividend yield. The low beta (≈0.5) and moderate 30‑day volatility (16%) further temper risk, making PKBK an attractive blend of growth and value.
Fundamentally, the stock appears markedly undervalued: a trailing P/E of 9.1 is well below the industry average of 17.2, and the DCF‑derived fair value of $93.7 suggests a >200% upside. Strong operating margins (70% operating, 50% profit), a modest 35% revenue growth year‑over‑year, and a low payout ratio of 20% support a sustainable 2.26% dividend yield. The low beta (≈0.5) and moderate 30‑day volatility (16%) further temper risk, making PKBK an attractive blend of growth and value.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical setup with price above key SMAs
- Support level intact and upside potential to resistance
- Attractive dividend yield with low payout ratio
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation gap versus DCF fair value
- Strong revenue growth and high operating margins
- Low beta indicating defensive characteristics in a regional‑bank sector
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustained undervaluation relative to peers
- Stable cash generation and manageable debt profile
- Consistent dividend sustainability supporting total return
Key Metrics & Analysis
Financial Health
Revenue Growth35.30%
Profit Margin50.21%
P/E Ratio9.1
ROE13.05%
ROA1.92%
P/B Ratio1.1
Op. Cash Flow$45.6M
Industry P/E17.2
Technical Analysis
TrendBullish
RSI59.3
Support$30.07
Resistance$32.44
MA 20$31.34
MA 50$30.61
MA 200$26.10
MACDBullish
VolumeDecreasing
Fear & Greed Index91.32
Valuation
Fair Value$93.71
GradeUndervalued
TypeBlend
Dividend Yield2.26%
Risk Assessment
Beta0.60
Volatility16.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.